The National Institute for Health Research-funded Clinical Research Network has appointed a new Cluster and Alliance lead, as well as new team members to take the lead on specific projects.
Funded by the National Institute for Health Research, Newcastle University is host to the Clinical Research Network (CRN) speciality Cluster Hub which has a national remit to oversee approximately 700 studies worth an estimated £300M in the speciality areas of Ageing, Dementias, Neurodegenerative Diseases, Neurological Disorders and Genetics.
Changes to the CRN Cluster Hub Team
Professor Lynn Rochester has been appointed Cluster and Alliance Lead, taking over from Professor Stuart Parker who retired in March 2018. As the Lead, Lynn will be a national ambassador for the Clinical Research Network. She will be part of the national leadership team within the Clinical Research Network Coordinating Centre, working closely with and reporting to the Medical Director, and alongside the Executive Team. She will represent Newcastle University within the NIHR CRN Alliance providing leadership, direction and oversight.
Lynn is Professor of Human Movement Science in the Institute of Neuroscience, Newcastle University. She is Director of the Clinical Ageing Research Unit (CARU), an NIHR funded translational clinical research facility aimed at research into conditions associated with ageing with a strong representation from the specialities represented in Cluster E.
She leads the Brain and Movement Research Group (BAM), comprised of a multidisciplinary team of clinicians, clinical scientists and clinical engineers with a research focus on age related gait and mobility disorders.
Ella Anderson joins the team as a Project Coordinator. Ella will be responsible for the smooth running of our Emerging Technology and Innovation Project “Innovations in Clinical Trial Design and Delivery for under-represented groups” among other cluster and specialty projects.
Lara Hope will be the new Administrative Officer working with the DeNDRoN Dementias, DeNDRoN Neurodegeneration and Neurological Diseases National Specialty Groups.